Evidence map›Paper›PMID 26833794›Full record

ArticleThe European journal of neuroscience2016

Searching for cognitive enhancement in the Morris water maze: better and worse performance in D-amino acid oxidase knockout (Dao(-/-)) mice.

David Pritchett, Amy M Taylor, Christopher Barkus, Sandra J Engle, Nicholas J Brandon, Trevor Sharp, Russell G Foster, Paul J Harrison, Stuart N Peirson, David M Bannerman

Open access · hybridAbstract read
In one paragraph

Article in The European journal of neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. NMDARs, Coincidence Detectors of Astrocytic and Neuronal Activities.International journal of molecular sciences · 2021
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Evaluation of Acute and Chronic Effects of D-Galactose on Memory and Learning in Wistar Rats.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2018
    Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

David PritchettNuffield Department of Clinical Neurosciences (Nuffield Laboratory of Ophthalmology), John Radcliffe Hospital, University of Oxford, Oxford, UK.
Amy M TaylorDepartment of Experimental Psychology, University of Oxford, Tinbergen Building, 9 South Parks Road, Oxford, OX1 3UD, UK.
Christopher BarkusDepartment of Pharmacology, University of Oxford, Oxford, UK.
Sandra J EnglePfizer Inc., Groton, CT, USA.
Nicholas J BrandonPfizer Inc., Groton, CT, USA.
Trevor SharpDepartment of Pharmacology, University of Oxford, Oxford, UK.
Russell G FosterNuffield Department of Clinical Neurosciences (Nuffield Laboratory of Ophthalmology), John Radcliffe Hospital, University of Oxford, Oxford, UK.
Paul J HarrisonDepartment of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK.
Stuart N PeirsonNuffield Department of Clinical Neurosciences (Nuffield Laboratory of Ophthalmology), John Radcliffe Hospital, University of Oxford, Oxford, UK.
David M BannermanDepartment of Experimental Psychology, University of Oxford, Tinbergen Building, 9 South Parks Road, Oxford, OX1 3UD, UK.
University of Oxford · GBJohn Radcliffe Hospital · GBPfizer (United States) · USWarneford Hospital · GB

Funding

Biotechnology and Biological Sciences Research CouncilMedical Research CouncilWellcome Trust 074385Wellcome Trust 087736Wellcome Trust 098461/Z/12/Z
6 · The paper itself

Abstract

A common strategy when searching for cognitive-enhancing drugs has been to target the N-methyl-d-aspartate receptor (NMDAR), given its putative role in synaptic plasticity and learning. Evidence in favour of this approach has come primarily from studies with rodents using behavioural assays like the Morris water maze. D-amino acid oxidase (DAO) degrades neutral D-amino acids such as D-serine, the primary endogenous co-agonist acting at the glycine site of the synaptic NMDAR. Inhibiting DAO could therefore provide an effective and viable means of enhancing cognition, particularly in disorders like schizophrenia, in which NMDAR hypofunction is implicated. Indirect support for this notion comes from the enhanced hippocampal long-term potentiation and facilitated water maze acquisition of ddY/Dao(-) mice, which lack DAO activity due to a point mutation in the gene. Here, in Dao knockout (Dao(-/-) ) mice, we report both better and worse water maze performance, depending on the radial distance of the hidden platform from the side wall of the pool. Dao(-/-) mice displayed an increased innate preference for swimming in the periphery of the maze (possibly due to heightened anxiety), which facilitated the discovery of a peripherally located platform, but delayed the discovery of a centrally located platform. By contrast, Dao(-/-) mice exhibited normal performance in two alternative assays of long-term spatial memory: the appetitive and aversive Y-maze reference memory tasks. Taken together, these results question the proposed relationship between DAO inactivation and enhanced long-term associative spatial memory. They also have generic implications for how Morris water maze studies are performed and interpreted.

Indexed as

CognitionMaze LearningAnimalsD-Amino-Acid OxidaseFemaleMaleMemory, Long-TermMiceSpatial MemoryD-Amino-Acid OxidaseDao1 protein, mouseD-serineglutamateN-methyl-d-aspartate receptorpre-clinical modelschizophrenia

Identifiers

PMID26833794
PMCPMC4855640
OpenAlexW2262709143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.